The dual topoisomerase inhibitor, BN 80927, is highly potent against cell proliferation and tumor growth

Ann N Y Acad Sci. 2000;922:303-5. doi: 10.1111/j.1749-6632.2000.tb07049.x.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Camptothecin / analogs & derivatives*
  • Camptothecin / pharmacology*
  • Cell Division / drug effects
  • Enzyme Inhibitors / pharmacology*
  • Growth Inhibitors / pharmacology*
  • Humans
  • Irinotecan
  • Male
  • Mice
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / pathology
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • BN 80927
  • Enzyme Inhibitors
  • Growth Inhibitors
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors
  • Irinotecan
  • Camptothecin